Molecular viral oncology of hepatocellular carcinoma

Oncogene

Volumn 22, Issue 33 REV. ISS. 2, 2003, Pages 5093-5107

  Block, Timothy M ^a   Mehta, Anand S ^a   Fimmel, Claus J ^a,b   Jordan, Robert ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hepatitis B; Hepatitis C; Hepatocellular carcinoma; Liver cancer

Indexed keywords

ALBUMIN; ALDEHYDE DEHYDROGENASE; AMINE OXIDASE (FLAVIN CONTAINING); BETA CATENIN; C REACTIVE PROTEIN; CD34 ANTIGEN; CELL CYCLE PROTEIN; CHYMOTRYPSIN; CORE PROTEIN; CYCLIN DEPENDENT KINASE 4; CYCLINE; CYTOCHROME; GELATINASE; GLUTATHIONE TRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; NONSTRUCTURAL PROTEIN 5A; PROTEIN KINASE C; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TRYPSIN INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS ENZYME; VIRUS PROTEIN; WNT PROTEIN;

GENE EXPRESSION; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; VIRUS GENOME; VIRUS REPLICATION; BIOLOGICAL MODEL; GENE EXPRESSION REGULATION; GENETICS; LIVER; LIVER TUMOR; PATHOGENICITY; TIME; VIROLOGY;

DNA VIRUSES; HEPATITIS B VIRUS; HEPATITIS C VIRUS;

CARCINOMA, HEPATOCELLULAR; GENE EXPRESSION REGULATION, VIRAL; HEPACIVIRUS; HEPATITIS B VIRUS; HUMANS; LIVER; LIVER NEOPLASMS; MODELS, BIOLOGICAL; PHENOTYPE; TIME FACTORS;

EID: 0042968962     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206557     Document Type: Review

References (117)

1. Arima N, Kao CY, Licht T, Padmanabhan R and Sasaguri Y. (2001). Modulation of cell growth by the hepatitis C virus nonstructural protein NS5A. J. Biol. Chem., 276, 12675-12684.
2. Baldwin AS. (1996). The NFkB and IkB proteins: new discoveries and insights. Ann. Rev. Immunol., 14, 649-681.
3. Bartenschlager R and Lohmann V. (2000). Replication of hepatitis C virus. J. Gen. Virol., 81, 1631-1648.
4. Benhar M, Dalyot I, Engelberg D and Levitzki A. (2001). Enhanced ROS production in oncogenically transformed cells potentiates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase activation and sensitization to genotoxic stress. Mol. Cell. Biol., 21, 6913-6926.
5. Blight K, Kolykhalov AA and Rice CM. (2000). Efficient initiation of HCV RNA replication in cell culture. Science, 290, 1972-1974.
6. Bouchard MJ, Wang LH and Schneider RJ. (2001). Calcium signaling by HBx protein in hepatitis B virus DNA replication. Science, 294, 2376-2378.
7. Brechot C, Gozuacik D, Murakami Y and Paterlini-Brechot P. (2000). Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). Semin. Cancer Biol., 10, 211-231.
8. Cerny A and Chisari FV. (1999). Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. Hepatology, 30, 595-601.
9. Chen X, Cheung ST, So S, Fan ST, Barry C, Higgins J, Lai KM, Ji J, Dudoit S, Ng IO, Van De RM, Botstein D and Brown PO. (2002). Gene expression patterns in human liver cancers. Mol. Biol. Cell, 13, 1929-1939.
10. Chen HS, Kaneko S, Girones R, Anderson RW, Hornbuckle WE, Tennant BC, Cote PJ, Gerin JL, Purcell RH and Miller RH. (1993). The woodchuck hepatitis virus x gene is important for establishment of virus infection in woodchucks. J. Virol., 67, 1218-1226.
11. Chen CM, You LR, Hwang LH and Lee YH. (1997). Direct interaction of hepatitis C virus core protein with the cellular lymphotoxin-beta receptor modulates the signal pathway of the lymphotoxin-beta receptor. J. Virol., 71, 9417-9426.
12. Chisari FV and Ferrari C. (1995). Hepatitis B virus immunopathology. Springer Semin. Immunopathol., 17, 261-281.
13. Chisari FV, Filippi P, Buras J, McLachlan A, Popper H, Pinkert CA, Palmiter RD and Brinster RL. (1987). Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice. Proc. Natl. Acad. Sci. USA, 84, 6909-6913.
14. Cocquerel L, Duvet S, Meunier JC, Pillez A, Cacan R, Wychowski C and Dubuisson J. (1999). The transmembrane domain of hepatitis C virus glycoprotein E1 is a signal for static retention in the endoplasmic reticulum. J. Virol., 73, 2641-2649.
15. Cocquerel L, Meunier J, Pillez A, Wychowski C and Dubuisson J. (1998). A retention signal necessary and sufficient for endoplasmic reticulum localization maps to the transmembrane domain of hepatitis c virus glycoprotein E2. J. Virol., 72, 2183-2191.
16. Collins AR. (1999). Oxidative DNA damage, antioxidants, and cancer. BioEssays, 21, 238-246.
17. den Boon JA, Chen J and Ahlquist P. (2001). Identification of sequences in Brome mosaic virus replicase protein 1a that mediate association with endoplasmic reticulum membranes. J. Virol., 75, 12370-12381.
18. Di Bisceglie AM. (1997). Hepatitis C and hepatocellular carcinoma. Hepatology, 26, 34S-38S.
19. Duvet S, Cocquerel L, Pillez A, Cacan R, Verbert A, Moradpour D, Wychowski C and Dubuisson J. (1999). Hepatitis C virus glycoprotein complex localizatin in the endoplasmic reticulum involves a determinant for retention and not retrieval. J. Biol. Chem., 273, 32088-32095.
20. Egger D, Wolk B, Gosert R, Bianchi L, Blum HE, Maradpour D and Bienz K. (2002). Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex. J. Virol., 76, 5974-5984.
21. El Serag HB and Mason AC. (1999). Rising incidence of hepatocellular carcinoma in the United States. N. Engl. J. Med., 340, 745-750.
22. El Serag HB, Mason AC and Key C. (2001). Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States. Hepatology, 33, 62-65.
23. Evans AA, O'Connell AP, Pugh JC, Mason WS, Shen FM, Chen GC, Lin WY, Dia A, M'Boup S, Drame B and London WT. (1998). Geographic variation in viral load among hepatitis B carriers with differing risks of hepatocellular carcinoma. Cancer Epidemiol. Biomarkers Prev., 7, 559-565.
24. Feitelson MA. (1999). Hepatitis B virus in hepatocarcinogenesis. J. Cell Physiol., 181, 188-202.
25. Finkel T and Holbrook NJ. (2000). Oxidants, oxidative stress and the biology of ageing. Nature, 408, 239-247.
26. Flint M and McKeating JA. (1999). The c-terminal region of the hepatitis C virus E1 glycoprotein confers localization within the endoplasmic reticulum. J. Gen. Virol., 80, 1943-1947.
27. Forns X, Purcell RH and Bukh J. (1999). Quasispecies in viral persistence and pathogenesis of hepatitis C virus. Trends Cell Biol.
28. Fourel G, Trepo C, Bougueleret L, Henglein B, Ponzetto A, Tiollais P and Buendia MA. (1990). Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumours. Nature, 20, 347:294-298.
29. Friedman SL. (2000). Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J. Biol. Chem., 275, 2247-2250.
30. Gale MJ, Blakely CM, Kwieciszewski B, Tan S, Dossett M, Tang NM, Korth MJ, Polyak SJ, Gretch DR and Katze MG. (1998). Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanism of kinase regulation. Mol. Cell. Biol., 18, 5208-5218.
31. Gale MJ, Korth MJ, Tang NM, Tan SI, Hopkins DA, Dever TE, Polyak SJ, Gretch DR and Katze MG. (1997). Evidence that hepatitis C virus resistance to inteferon is mediated through repression of the PKR protein kinase by the nostructural 5a protein. Virology, 230, 217-227.
32. Gale Jr M, Kwieciszewski B, Dossett M, Nakao H and Katze MG. (1999). Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase. J. Virol., 73, 6506-6516.
33. Gass JN, Gifford NM and Brewer JW. (2002). Activation of an unfolded protein response during differentiation of antibody-secreting B cells. J. Biol. Chem.
34. Gerotto M, Sullivan DG, Polyak SJ, Chemello L, Cavalletto L, Pontisso P, Alberti A and Gretch DR. (1999). Effect of retreatment with interferon alone or interferon plus ribavirin on hepatitis C virus quasispecies diversification in nonresponder patients with chronic hepatitis C. J. Virol., 73, 7241-7247.
35. Ghosh AK, Majumder M, Steele R, Meyer K, Ray R and Ray RB. (2000). Hepatitis C virus NS5A protein protects against TNF-alpha mediated apoptotic cell death. Virus Res., 67, 173-178.
36. Ghosh AK, Steele R, Meyer K, Ray R and Ray RB. (1999). Hepatitis C virus NS5A protein modulates cell cycle regulatory genes and promotes cell growth. J. Gen. Virol., 80(Part 5), 1179-1183.
37. Gong G, Waris G, Tanveer R and Siddiqui A. (2001). Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B. Proc. Natl. Acad. Sci., 98, 9599-9604.
38. Gozuacik D, Murakami Y, Saigo K, Chami M, Mugnier C, Lagorce D, Okanoue T, Urashima T, Brechot C and Paterlini-Brechot P. (2001). Identification of human cancer-related genes by naturally occurring hepatitis B virus DNA tagging. Oncogene, 20, 6233-6240.
39. Guidotti LG, Morris A, Mendez H, Koch R, Silverman RH, Williams BR and Chisari FV. (2002). Interferon-regulated pathways that control hepatitis B virus replication in transgenic mice. J. Virol., 76, 2617-2621.
40. Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell RH and Chisari FV. (1999). Viral clearance without destruction of infected cells during acute HBV infection. Science, 284, 825-829.
41. 2. J. Biol. Chem., 271, 4138-4142.
42. Hagen TM, Huang S, Curnutte J, Fowler P, Martinez V, Wehr CM, Ames BN and Chisari FV. (1994). Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma. Proc. Natl. Acad. Sci., 91, 12808-12812.
43. Hsu HC, Tseng HJ, Lai PL, Lee PH and Peng SY. (1993). Expression of p53 gene in 184 unifocal hepatocellular carcinomas: association with tumor growth and invasiveness. Cancer Res., 53, 4691-4694.
44. Hu J, Toft DO and Seeger C. (1997). Hepadnavirus assembly and reverse transcription require a multi-component chaperone complex which is incorporated into nucleocapsids. EMBO J., 16, 59-68.
45. Hu Z, Zhang Z, Doo E, Coux O, Goldberg AL and Liang TJ. (1999). Hepatitis B virus x protein is both a substrate and a potential inhibitor of the proteasome complex. J. Virol., 73, 7231-7240.
46. Hugle T, Fehrmann F, Bieck E, Kohara M, Krausslich H, Rice CM, Blum HE and Maradpour D. (2001). The hepatitis C virus nonstructural protein 4B is an integral endoplasmic reticulum membrane protein. Virology, 284, 70-81.
47. Hurlimann J and Gardiol D. (1991). Immunohistochemistry in the differential diagnosis of liver carcinomas. Am. J. Surg. Pathol., 15, 280-288.
48. Israel J, Unger E, Buetow K, Brown T, Blumberg B and London WT. (1989). Correlation between liver iron content magnetic resonance imaging in rats. Magn. Reson. Imaging, 7, 629-634.
49. Jordan R, Nikolaeva O, Wang L, Conyers B, Mehta A, Dwek RA and Block TM. (2002a). Inhibition of host ER glucosidase activity prevents Golgi processing of virion-associated bovine viral diarrhea virus E2 glycoproteins and reduces infectivity of secreted virions. Virology, 295, 10-19.
50. Jordan R, Wang L, Graczyk TM, Block TM and Romano PR. (2002b). Replication of a cytopathic strain of bovine viral diarrhea virus activates PERK and induces endoplasmic reticulum stress-mediated apoptosis of MDBK cells. J. Virol., 76, 9588-9599.
51. Kakimi K, Lane TE, Chisari FV and Guidotti LG. (2001). Cutting edge: inhibition of hepatitis B virus replication by activated NK T cells does not require inflammatory cell recruitment to the liver. J. Immunol., 167, 6701-6705.
52. Kaufman RJ. (1999a). Double-stranded RNA-activated protein kinase mediates virus-induced apoptosis: a new role for an old actor. Proc. Natl. Acad. Sci., 96, 11693-11695.
53. Kaufman RJ. (1999b). Stress signaling from the lumen of the endoplasmic retiuclum: coordination of gene transcriptional and translational controls. Genes Dev., 13, 1211-1233.
54. Kinoshita T and Miyajima A. (2002). Cytokine regulation of liver development. Biochim. Biophys. Acta, 1592, 303-312.
55. Kittlesen DJF, Chianese-Bullock KAF, Yao ZQF, Braciale TJF and Hahn YS. (2000). Interaction between complement receptor gClqR and hepatitis C virus core protein inhibits T-lymphocyte proliferation. J. Clin. Invest., 106, 1239-1249.
56. Kladney R, Tollefson A, Wold W and Fimmel C. (2002). Upregulation of the golgi protein GP73 by adenovirus infection requires the E1A CtBP interaction domain. Virology, 301, 236-246.
57. Lee WM, Ishikawa M and Ahlquist P. (2001). Mutation of host {Delta}9 fatty acid desaturase inhibits brome mosaic virus RNA replication between template recognition and RNA synthesis. J. Virol., 75, 2097-2106.
58. Liang TJ, Rehermann B, Seeff LB and Hoofnagle JH. (2000). Pathogenesis, natural history, treatment, and prevention of hepatitis C. Annu. Intern. Med., 132, 296-305.
59. Lohmann V, Korner F, Dobierzewska A and Bartenschlager R. (2001). Mutations in hepatitis C virus RNAs conferring cell culture adaptation. J. Virol., 75, 1437-1449.
60. Lohmann V, Korner F, Koch J, Herian U, Theilmann L and Bartenschlager R. (1999). Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science, 285, 110-113.
61. Lok AS, Heathcote EJ and Hoofnagle JH. (2001). Management of hepatitis B: 2000 - summary of a workshop. Gastroenterology, 120, 1828-1853.
62. Ma Y and Hendershot LM. (2001). The unfolding tale of the unfolded protein response. Cell, 107, 827-830.
63. Mackenzie JM and Westaway EG. (2001). Assembly and maturation of the flavivirus Kunjin virus appear to occur in the rough endoplasmic reticulum and along the secretory pathway, respectively. J. Virol., 75, 10787-10799.
64. Matsubara K and Tokino T. (1990). Integration of hepatitis B virus DNA and its implications for hepatocarcinogenesis. Mol. Biol. Med., 7, 243-260.
65. Matsumoto M, Hsieh TY, Zhu N, VanArsdale T, Hwang SB, Jeng KS, Gorbalenya AE, Lo SY, Ou JH, Ware CF and Lai MM. (1997). Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor. J. Virol., 71, 1301-1309.
66. McCullough KD, Martindale JL, Klotz L, Aw T and Holbrook NJ. (2000). Gadd153 sensitizes cells to endoplsmic reticulum stress by down-regulating bcl2 and perturbing the cellular redox state. Mol. Cell. Biol., 21, 1249-1259.
67. Menne S, Roneker CA, Roggendorf M, Gerin JL, Cote PJ and Tennant BC. (2002). Deficiencies in the acute-phase cell-mediated immune response to viral antigens are associated with development of chronic woodchuck hepatitis virus infection following neonatal inoculation. J. Virol., 76, 1769-1780.
68. Menne S and Tennant BC. (1999). Unraveling hepatitis B virus infection of mice and men (and woodchucks and ducks). Nat. Med., 5, 1125-1126.
69. Montalto G, Cervello M, Giannitrapani L, Dantona F, Terranova A and Castagnetta LA. (2002). Epidemiology, risk factors, and natural history of hepatocellular carcinoma. Ann. NY Acad. Sci., 963, 13-20.
70. Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, Tsutsumi T, Ishibashi K, Matsuura Y, Kimura S, Miyamura T and Koike K. (1998). The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat. Med., 4, 1065-1067.
71. Moriya K, Nakagawa K, Santa T, Shintani Y, Fujie H, Miyoshi H, Tsutsumi T, Miyazawa T, Ishibashi K, Horie T, Imai K, Todoroki T, Kimura S and Koike K. (2001). Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res., 61, 4365-4370.
72. Mottola G, Cardinali G, Ceccacci A, Trozzi C, Bartholomew L, Rosaria M, Pedrazzini E, Bonatti S and Migliaccio G. (2001). Hepatitis C virus nonstructural proteins are localized in a modified endoplasmic reticulum of cells expressing viral subgenomic replicons. Virology, 293, 31-43.
73. Nejjari M, Hafdi Z, Gouysse G, Fiorentino M, Beatrix O, Dumortier J, Pourreyron C, Barozzi C, D'errico A, Grigioni WF and Scoazec JY. (2002). Expression, regulation, and function of alpha V integrins in hepatocellular carcinoma: an in vivo and in vitro study. Hepatology, 36, 418-426.
74. Park KS, Cho SY, Kim H and Paik YK. (2002). Proteomic alterations of the variants of human aldehyde dehydrogenase isozymes correlate with hepatocellular carcinoma. Int. J. Cancer, 97, 261-265.
75. Parkin DM, Bray F, Ferlay J and Pisani P. (2001). Estimating the world cancer burden: Globocan 2000. Int. J. Cancer, 94, 153-156.
76. Pietschmann T, Lohmann V, Kaul A, Krieger N, Gabriele R, Rutter G, Strand D and Bartenschlager R. (2002). persistent and transient replication of full-length hepatitis C virus genomes in cell culture. J. Virol., 76, 4008-4021.
77. Pietschmann T, Lohmann V, Rutter G, Kurpanek K and Bartenschlager R. (2001). Characterization of cell lines carrying self-replicating hepatitis C virus RNAs. J. Virol., 75, 1252-1264.
78. Polyak SJ, Paschal DM, McArdle S, Gale Jr MJ, Moradpour D and Gretch DR. (1999). Characterization of the effects of hepatitis C virus nonstructural 5A protein expression in human cell lines and on interferon-sensitive virus replication. Hepatology, 29, 1262-1271.
79. Potapova O, Gorospe M, Bost F, Dean NM, Garrde WA, Mercola D and Holbrook NJ. (2000). c-Jun N-terminal kinase is essential for growth of human T98G glioblastoma cells. J. Biol. Chem., 275, 24767-24775.
80. Preikschat P, Gunther S, Reinhold S, Will H, Budde K, Neumayer HH, Kruger DH and Meisel H. (2002). Complex HBV populations with mutations in core promoter, C gene, and pre-S region are associated with development of cirrhosis in long-term renal transplant recipients. Hepatology, 35, 466-477.
81. Rehermann B, Lau D, Hoofnagle JH and Chisari FV. (1996). Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection. J. Clin. Invest., 97, 1655-1665.
82. Robinson MJ and Cobb MH. (1997). Mitogen-activated protein kinase pathways. Curr. Opin. Cell Biol., 9, 180-186.
83. Schlesinger MJ and Malfer C. (1982). Cerulenin blocks fatty acid acylation of glycoproteins and inhibits vesicular stomatitis and Sindbis virus particle formation. J. Biol. Chem., 257, 9887-9890.
84. Seeger C and Mason WS. (2000). Hepatitis B virus biology. Microbiol. Mol. Biol. Rev., 64, 51-68.
85. Sekine S, Shibata T, Sakamoto M and Hirohashi S. (2002). Target disruption of the mutant beta-catenin gene in colon cancer cell line HCT116: preservation of its malignant phenotype. Oncogene, 21, 5906-5911.
86. Shackel NA, McGuinness PH, Abbott CA, Gorrell MD and McCaughan GW. (2002). Insights into the pathobiology of hepatitis C virus-associated cirrhosis: analysis of intrahepatic differential gene expression. Am. J. Pathol., 160, 641-654.
87. Shimoda R, Nagashima M, Sakamoto M, Yamaguchi N, Hirohashi S, Yokota J and Kasai H. (1994). Increased formation of oxidative DNA damage, 8-hydroxydeoxyguanosine, in human livers with chronic hepatitis. Cancer Res., 54, 3171-3172.
88. Shrivastava A, Manna SK, Ray R and Aggarwal BB. (1998). Ectopic expression of hepatitis C virus core protein differentially regulates nuclear transcription factors. J. Virol., 72, 9722-9728.
89. Sirma H, Weil R, Rosmorduc O, Urban S, Israel A, Kremsdorf D and Brechot C. (1998). Cytosol is the prime compartment of hepatitis B virus x protein where it colocalizes with the proteasome. Oncogene, 16, 2051-2063.
90. Song J, Fujii M, Wang F, Itoh M and Hotta H. (1999). The NS5a protein of hepatitis C virus partially inhibits the antiviral activity of interferon. J. Gen. Virol., 80, 879-886.
91. Steel LF, Mattu TS, Mehta A, Hebestreit H, Dwek R, Evans AA, London WT and Block T. (2001). A proteomic approach for the discovery of early detection markers of hepatocellular carcinoma. Dis. Markers, 17, 179-189.
92. Steel LF, Shumpart D, Trotter M, Seeholzer SH, Evans AA, London WT, Dwek R and Block T M. (2003). A strategy for the comparative analysis of serum proteins for the discovery of biomarkers for hepatocellular carcinoma. Proteomic: in press.
93. Stevens RG, Graubard BI, Micozzi MS, Neriishi K and Blumberg BS. (1994). Moderate elevation of body iron level and increased risk of cancer occurrence and death. Int. J. Cancer, 56, 364-369.
94. Sumida Y, Nakashima T, Yoh T, Nakjima Y, Ishikawa H, Mitsuyoshi H, Sakamoto Y, Okanoue T, Kashima K, Nakamura H and Yodoi J. (2000). Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infection. J. Hepatology, 33, 616-622.
95. Sun J, Bodola F, Fan X, Irshad H, Soong L, Lemon SM and Chan TS. (2001). Hepatitis C virus core and envelope proteins do not suppress the host's ability to clear a hepatic viral infection. J. Virol., 75, 11992-11998.
96. Tai D, Tsai S, Chen Y, Chaung Y, Peng C, Sheen I, Yeh C, Chang KSS, Huang S, Kuo GC and Liaw YF. (2000). Activation of nuclear factor kB in hepatitis C virus infection: implications for pathogenesis and hepatocarcinogenesis. Hepatology, 31, 656-664.
97. Tai PC, Suk FM, Gerlich WH, Neurath AR and Shih C. (2002). Hypermodification and immune escape of an internally deleted middle-envelope (M) protein of frequent and predominant hepatitis B virus variants. Virology, 292, 44-58.
98. Tan S and Katze MG. (2001). How hepatitis C virus counteracts the interferon response: the jury is still out on NS5A. Virology, 284, 1-12.
99. Tardif KD, Mori K and Siddiqui A. (2002). Hepatitis C virus subgenomic replicons induce endoplasmic reticulum stress activating an intracellular signaling pathway. J. Virol., 76, 7453-7459.
100. Tennant BC and Gerin JL. (1994). The Liver: Biology and pathobiology, Arias IM, Faustto N, Jacoby WB, Boyer JL, Schacter DA and Shafritz DA (eds). Raven press: New York, 1455-1466.
101. Wang X, Martindale JL, Liu Y and Holbrook NJ. (1999). The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival. Biochem. J., 333, 291-300.
102. Waris G, Tardif KD and Siddiqui A. (2002). Endoplasmic reticulum (ER) stress: hepatitis C virus induces an ER-nucleus signal transduction pathway and activates NF-kappaB and STAT-3. Biochem. Pharmacol., 64, 1425-1430.
103. Webster G and Bertoletti A. (2001). Quantity and quality of virus-specific CD8 cell response: relevance to the design of a therapeutic vaccine for chronic HBV infection. Mol. Immunol., 38, 467-473.
104. Webster GJM, Reignat S, Maini MK, Whalley SA, Ogg GS, King A, Brown D, Amlot PL, Williams R, Vergani D, Dusheiko GM and Bertoletti A. (2000). Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology, 32, 1117-1124.
105. Weiland F, Eiland E, Nger G, Sallmuller A and Thiel H. (1999). Localization of pestivrial envelope proteins Erns and E2 at the cell surface and on isolated particles. J. Gen. Virol., 80, 1157-1165.
106. Westaway EG, Mackenzie JM, Kenney MT, Jones MK and Khromykh AA. (1997). Ultrastructure of Kunjin virus-infected cells: colocalization of NS1 and NS3 with double-stranded RNA, and of NS2B with NS3, in virus-induced membrane structures. J. Virol., 71, 6650-6661.
107. Wolk B, Sansonno D, Krausslich HG, Dammacco F, Rice CM, Blum HE and Moradpour D. (2000). Subcellular localization, stability, and trans-cleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline-regulated cell lines. J. Virol., 74, 2293-2304.
108. Wu CG, Forgues M, Siddiqui A, Farnsworth J, Velerie K and Wang XW. (2002). SAGE transcript profiles of normal primary human hepatocytes expressing oncogenic hepatitis B virus x protein. FASEB J. 10, 1665-1667.
109. Xia Z, Dickens M, Raingeaud J, Davis RJ and Greenberg ME. (1995). Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science, 270, 1326-1331.
110. Xu XR, Huang J, Xu ZG, Qian BZ, Zhu ZD, Yan Q, Cai T, Zhang X, Xiao HS, Qu J, Liu F, Huang QH, Cheng ZH, Li NG, Du JJ, Hu W, Shen KT, Lu G, Fu G, Zhong M, Xu SH, Gu WY, Huang W, Zhao XT, Hu GX, Gu JR, Chen Z and Han ZG. (2001). Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc. Natl. Acad. Sci. USA, 98, 15089-15094.
111. Xu Z, Jensen G and Yen TS. (1997). Activation of hepatitis B virus S promoter by the viral large surface protein via induction of stress in the endoplasmic reticulum. J. Virol., 71, 7387-7392.
112. Yeh CT. (2000). Hepatitis B virus x protein: searching for a role in hepatocarcinogenesis. J. Gastroenterol. Hepatol., 15, 339-341.
113. You LR, Chen CM, Yeh TS, Tsai TY, Mai RT, Lin CH and Lee YHW. (1999). Hepatitis C virus core protein interacts with cellular putative RNA helicase. J. Virol., 73, 2841-28533.
114. Yu LR, Zeng R, Shao XX, Wang N, Xu YH and Xia QC. (2000). Identification of differentially expressed proteins between human hepatoma and normal liver cell lines by two-dimensional electrophoresis and liquid chromatography-ion trap mass spectrometry. Electrophoresis, 21, 3058-3068.
115. Zhou T, Evans AA, London WT, Xia XX, Zou H, Shen F-min and Clapper ML. (1997). Glutathionine S transferase expression in hepatitis virus associated human hepatocellular carcinogenesis. Cancer Res., 57, 2749-2753.
116. Zhu N, Ware CF and Lai MM. (2001). hepatitis c virus core protein enhances FADD-mediated apoptosis and suppresses TRADD signalin of tumor necrosis factor receptor. Virology, 283, 178-187.
117. Zoulim F, Saputelli J and Seeger C. (1994). Woodchuck hepatitis virus x protein is required for viral infection in vivo. J. Virol., 68, 2026-2030.